TNF and juvenile idiopathic arthritis: Golimumab is a fully humanized monoclonal anti-TNF antibody that is approved for use in axial SpA (AS and non-radiographic axial SpA), psoriatic arthritis (PsA), rheumatoid arthritis (RA), UC, polyarticular juvenile idiopathic arthritis (JIA), and PsA in pediatric patients [3]. Biologic medications are commonly used for the treatment of many autoimmune diseases.